🚫DEA Revokes Registration for Healthcare Fraud
The Drug Enforcement Administration has revoked the registration of Mark Agresti, M.D., due to healthcare fraud convictions. The order highlights the implications of mandatory exclusions from Medicare and Medicaid, emphasizing the stringent standards required for trustworthiness among healthcare providers and the consequences of failing to meet these standards.
Learn More⚖️DEA Revokes Physician's Registration
The Drug Enforcement Administration has issued a decision revoking the DEA registration of Dr. William Washington due to his lack of authority to practice medicine in Washington State. The order emphasizes the requirement for physicians to maintain state licensing to handle controlled substances, impacting compliance standards within the healthcare sector.
Learn More🚫DEA Revocation of Nurse Practitioner’s Registration
The Drug Enforcement Administration issued an Order to Show Cause proposing the revocation of Tanya Newlove's registration for handling controlled substances due to the expiration of her state nursing licenses. The agency highlights the critical requirement for practitioners to maintain valid state authority to dispense controlled substances, indicating significant compliance issues.
Learn More📄Notice of Correction for Medicare Information Collection Request
On June 12, 2025, CMS published a notice in the Federal Register seeking comment on a collection of information concerning CMS- 10106 (OMB control number 0938-0930) titled "Medicare Authorization to Disclose Personal Health Information." The number of total annual responses is incorrectly listed. This document corrects the error.
Learn More🩺CMS Notice for Proposed Information Collection on CLIA Applications
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Learn More🏥CMS Corrects Information Collection Notice for IRF Services
On June 27, 2025, CMS published a notice in the Federal Register that sought comment on a collection of information concerning CMS-10765 (OMB control number 0938-1420) entitled "Review Choice Demonstration for Inpatient Rehabilitation Facility (IRF) Services." The type of information collection request listed in the notice is incorrect. This document corrects the error.
Learn More⚖️DEA Revokes Registration of Dr. Loretta Clement - Key Outcomes
The Drug Enforcement Administration has revoked Dr. Loretta Clement's registration to prescribe and handle controlled substances due to her inactive medical license in Ohio. This action underscores the imperative for medical professionals to maintain proper state licensing to operate legally under federal law, reflecting ongoing regulatory enforcement in the healthcare sector.
Learn More📋CMS Notice on Information Collection and Medicare Agreement
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Learn More💊FDA Determines SYNDROS Not Withdrawn, Opens Doors for Generics
The Food and Drug Administration (FDA, Agency, or we) has determined that SYNDROS (dronabinol) solution, 5 milligrams (mg)/ milliliter (mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for SYNDROS (dronabinol) solution, 5 mg/ mL, if all other legal and regulatory requirements are met.
Learn More📋FDA Notice on Proposed Information Collection for 510(k) Reviews
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection associated with the 510(k) Third-Party Review Program.
Learn More